by Simran Chahal | Jun 19, 2014 | Health, News
The National Research Council of Canada (NRC) and Augurex Life Sciences Corp. are proud to announce a collaborative agreement to develop new treatments for rheumatoid arthritis through personalized medicine. By combining their research and development expertise, NRC...
by Simran Chahal | May 29, 2014 | Health, News
Vancouver, BC – May 29, 2014. Augurex Life Sciences Corp. announces a ground-breaking body of new data that will publish during the European League Against Rheumatism (EULAR) Annual Congress of Rheumatology taking place June 11-14 in Paris. Investigators will present...
by Simran Chahal | Oct 25, 2013 | Health, News
Vancouver, BC – October 25, 2013 – Augurex Life Sciences Corp. announced today the expansion of key data related to its innovative 14-3-3eta biomarkers with scheduled presentations next week at the prestigious American College of Rheumatology Annual Meeting,...
by Simran Chahal | Nov 14, 2012 | Health, News
International arthritis investigators this week at the 2012 Annual Meeting of the American College of Rheumatology held in Washington, DC presented data related to the 14-3-3η protein and its auto-antibodies, a promising set of new blood-based markers from Augurex,...
by Simran Chahal | Oct 9, 2012 | Health, News
Augurex Life Sciences Corp. today announced that it has formed an exclusive license agreement with Quest Diagnostics, for the development of a clinical laboratory-developed testing service for the U.S. market, based on Augurex’s rheumatoid arthritis (RA) 14-3-3η...
by Simran Chahal | Sep 6, 2012 | Health, News
When early discoveries are made at universities, they usually require additional research and funding to uncover what the innovation’s clinical usefulness will be to patients and physicians. For example, in 2006 researchers at the University of British Columbia...
